Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-25-008774
Filing Date
2025-03-21
Accepted
2025-03-21 17:20:22
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A opk20241231_10ka.htm   iXBRL 10-K/A 167130
2 EXHIBIT 19.1 ex_792993.htm EX-19.1 41221
3 EXHIBIT 31.1 ex_792996.htm EX-31.1 4032
4 EXHIBIT 31.2 ex_792997.htm EX-31.2 4072
  Complete submission text file 0001437749-25-008774.txt   465926

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA opk-20241231.xsd EX-101.SCH 3727
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20241231_def.xml EX-101.DEF 17402
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20241231_lab.xml EX-101.LAB 25273
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20241231_pre.xml EX-101.PRE 19421
20 EXTRACTED XBRL INSTANCE DOCUMENT opk20241231_10ka_htm.xml XML 7717
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33528 | Film No.: 25761592
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)